Skip to main content
Clinical Trials/NL-OMON43257
NL-OMON43257
Completed
Phase 2

Electrocortical activity during force control movements in patients with anterior cruciate ligament (ACL) reconstructions versus patients with ACL deficiency versus healthy controls. - Electrocortical Activity in Patients with ACL ruptures

Ziekenhuisgroep Twente0 sites27 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Neural plasticity/Changes in brain activation pattern
Sponsor
Ziekenhuisgroep Twente
Enrollment
27
Status
Completed
Last Updated
last year

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
June 7, 2018
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
Ziekenhuisgroep Twente

Eligibility Criteria

Inclusion Criteria

  • General inclusion criteria:
  • \- Tegnerscore \> 4
  • \- Age between 18 and 30 years at the moment of inclusion
  • \- The right leg is the dominant leg;Additional inclusion criteria ACL reconstruction group:
  • \- primary ACL reconstruction
  • \- Date of measurement and date of reconstruction are not less than nine months but not more than fifteen months from each other.
  • \- Date of rupture and date of reconstruction surgery are not more than five months from each other.;Additional inclusion criteria ACL deficient group:
  • \- Date of measurement and date of rupture are not less than seven months but not more than seventeen months from each other. ;Additional inclusion criteria control group:
  • \- No knee damage (bilateral) in history
  • \- No physical limitations at the moment of measurement

Exclusion Criteria

  • \- Complications during rehabilitation (re\-ruptures, additional knee damage and/or no (expected) functional recovery after 12 months
  • \- Epilepsy and/or other brain diseases
  • \- Pregnancy;Additional for the ACL reconstructed and ACL deficient groups:
  • \- Additional ligament injury at the moment of ACL rupture
  • \- ACL deficiency or ACL reconstruction at the contralateral knee

Outcomes

Primary Outcomes

Not specified

Similar Trials